K-Y Liu
Overview
Explore the profile of K-Y Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
711
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Su J, Li N, Duan J, Zhang J, Liu K, Sun C
Eur Rev Med Pharmacol Sci
. 2023 May;
27(9):3846-3853.
PMID: 37203809
Objective: With the development and widespread use of fetal ultrasound and magnetic resonance technology in recent years, approximately 75% of fetuses are diagnosed prenatally with congenital structural malformations, a serious...
2.
Ling L, Hu H, Liu K, Ram Y, Gao J, Cao Y
Eur Rev Med Pharmacol Sci
. 2019 Dec;
23(23):10195-10203.
PMID: 31841172
Objective: To investigate the expression of long noncoding RNA (LncRNA) MIRG and its potential functions in regulating osteoclastogenesis and bone resorption function through modulating miR-1897 in bone marrow macrophages (BMMs)....
3.
Cao L, Liu L, Xu L, Zhang X, Wang Y, Fan Q, et al.
Bone Marrow Transplant
. 2017 Oct;
53(1):108-110.
PMID: 29058700
No abstract available.
4.
Wang Y, Wu D, Liu Q, Xu L, Liu K, Zhang X, et al.
Leukemia
. 2017 Jun;
32(2):492-498.
PMID: 28642591
Prior data indicate similar outcomes after transplants from human leukocyte antigen (HLA)-haplotype-matched relatives, HLA-identical siblings and HLA-matched unrelated donors. We used our prospective data set to answer a clinically important...
5.
Xu L, Wu D, Han M, Huang H, Liu Q, Liu D, et al.
Bone Marrow Transplant
. 2017 Apr;
52(11):1512-1518.
PMID: 28436973
Hematopoietic cell transplantation (HCT) activity in China was surveyed to assess its current status. A record number of HCTs (21 884: 16 631 allogeneic (76%) and 5253 autologous (24%)) were...
6.
Ma Y, Xu L, Zhang X, Yan C, Wang Y, Wang F, et al.
Bone Marrow Transplant
. 2016 Nov;
52(3):409-414.
PMID: 27797365
We investigated the impact of donor type on post-relapse survival (PRS) in 85 patients with hematological relapse after their first allogeneic hematological stem cell transplantation (allo-HSCT) for hematological malignancy. The...
7.
Mo X, Zhang X, Xu L, Wang Y, Yan C, Chen H, et al.
Transpl Infect Dis
. 2016 May;
18(4):492-503.
PMID: 27218435
Background: In this study, we aimed to evaluate the prognostic factors associated with and treatments for late-onset severe pneumonia (LOSP) in patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT)....
8.
Qin X, Wang Y, Li G, Qin Y, Wang F, Xu L, et al.
J Transl Med
. 2016 Apr;
14:100.
PMID: 27118383
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been established as an effective treatment for patients with hematological malignancies. Disease relapse remains a major cause of transplant failure. T cell...
9.
Sun Y, Xu L, Han T, Zhang X, Wang Y, Han W, et al.
Transpl Infect Dis
. 2015 Aug;
17(5):655-61.
PMID: 26275161
Background: Cytomegalovirus (CMV) enteritis after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is difficult to diagnose. We aimed to evaluate the sensitivity and specificity of the detection of CMV DNA in...
10.
Sun Y, Xu L, Zhang X, Liu D, Chen H, Wang Y, et al.
Bone Marrow Transplant
. 2015 Jan;
50(4):601-3.
PMID: 25599162
No abstract available.